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Purpose: To test the association of the X-chromosome regions (Xp21.1–q21.2 and Xq25–27.2) with Leber hereditary
optic neuropathy (LHON) in Chinese patients.
Methods: One hundred and seventy-five male LHON patients with the G11778A mutation and 100 unrelated normal
males participated. Twelve microsatellite markers and four single-nucleotide polymorphisms (SNPs) were genotyped for
patients and controls. A χ2 or Fisher’s exact test was used to compare the frequencies of genotypes as well as haplotypes
in the two groups.
Results:  Significant  differences  between  patients  and  controls  were  found  in  two  isolated  microsatellite  markers
(DXS6803: χ2=37.17, p=2.45×10−5; DXS984: χ2=33.88, p=1.66×10−6) based on genotype frequencies. However, no
significant differences for genotype and haplotype frequencies were found in the other 14 markers located in the two
reported regions of Xp21.1–q21.2 and Xq25–27.2.
Conclusions: Our results provide suggestive evidence of X-linked modifiers on the expression of LHON. Further studies
are needed to identify the exact nuclear genes that might affect LHON expression.
Leber  hereditary  optic  neuropathy  (LHON,  OMIM
535000)  is  one  of  the  best  studied  mitochondrial  genetic
diseases.  The  prevalence  of  LHON  is  about  1  in  8,500
individuals in the general population of North East England
[1]. The majority of LHON cases are caused by three common
mitochondrial DNA (mtDNA) mutations, G11778A in the
ND4 gene [2], T14484C in the ND6 gene [3,4], and G3460A
in the ND1 gene [5,6]. The distribution patterns of these three
primary mutations differ remarkably among populations of
Europe and East Asia [7,8] and about 90% of LHON cases
among Chinese are associated with the G11778A mutation
[8].
Only about one third of carriers of the three common
mutations will develop LHON, and male carriers have a much
higher  risk  of  developing  the  disease  than  females.  The
incomplete penetrance and sex bias of LHON are not well
explained by primary mtDNA mutations alone, suggesting
that environmental [9-11] or additional genetic factors may
contribute  to  the  expression  of  LHON.  Beyond  primary
mtDNA mutations, other genetic factors that might affect the
clinical  expression  of  LHON  include  additional  mtDNA
mutations [12], heteroplasmy [13,14], mtDNA haplogroup
[7,15-19], and potential nuclear genes such as X-chromosome
modified  loci  [20].  In  European  families,  clear  evidence
demonstrates that the risk of visual failure is higher when
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G11778A or T14484C mutations are present in haplogroup J
and when G3460A is present in haplogroup K, but is lower
when G11778A exists in haplogroup H [7]. The effect of
haplogroup J was narrowed to subclades J1c and J2b [19]. Our
previous  study  showed  that  haplogroup  M7b1’2  could
increase the risk of visual failure and that M8a might have a
protective  effect  in  Chinese  families  with  LHON,  which
(results of M7b12 and M8a) differ from those found among
Europeans  [21,22].  However,  the  effect  of  mtDNA
haplogroups could only partly explain the different penetrance
among different families. It could also not explain different
penetrance  within  the  same  family  where  all  maternal
offspring have the same mutation under the same mtDNA
background, yet some individuals develop the disease while
others do not, and male family members are more likely than
females to have the disease.
Previous segregation analysis found that some pedigrees
are consistent with an X-linked susceptibility allele [23,24],
leading to efforts to map and identify the suspected X-linked
modified gene. However, linkage analysis of X-chromosome
markers resulted in a series of inconsistent results [25-27].
Recently,  Hudson  et  al.  suggested  that  nuclear  modifiers
might be more common in the general population than the
relatively  rare  primary  mtDNA  mutations  [28].  Using  a
nonparametric  complex-disease-mapping  strategy,  they
identified  an  X-chromosomal  haplotype  DXS8090  (166)/
DXS1068 (258) in the Xp21.1–q21.2 region as a risk factor
in  Europeans,  which  is  independent  of  the  mtDNA
background and could well explain the variable penetrance
and sex bias in the studied pedigrees. In a recent study, X-
Molecular Vision 2010; 16:416-424 <http://www.molvis.org/molvis/v16/a47>
Received 7 August 2009 | Accepted 3 March 2010 | Published 11 March 2010
© 2010 Molecular Vision
416chromosomal linkage analysis in a large Brazilian family with
the  G11778A  mutation  on  a  haplogroup  J  background
revealed a novel LHON susceptibility locus on chromosome
Xq25–27.2 [29]. Considering the extreme high rate of false-
positive  results  in  genetic  association  studies  [30-35],
replication is the first priority in a genetic association study of
complex traits. In addition, it is necessary to test whether this
X-chromosome locus also affects the clinical expression of
LHON among Chinese, although we have seen differences in
mtDNA haplogroups [7,21] as well as in sex bias (the male to
female ratio was 2.2:1 to 2.4:1 among Chinese [8,21] but 3.7:1
to 12.4:1 in Caucasians [36-38]).
Here, we studied the distribution of the microsatellite and
SNP markers on the two reported loci and the reported high-
risk  haplotype  [DXS8090  (166)/DXS1068  (258)]  in  the
TABLE 1. PRIMERS USED TO AMPLIFY DNA FRAGMENTS ENCOMPASSING THE TWELVE MICROSATELLITE MARKERS AND THE FOUR SINGLE NUCLEAOTIDE POLYMORPHISMS.
Name Primer sequence (5′-3′) Length of product
(bp)
Annealing
temperature
DXS8090 M13 tailed-F-CGTTGTAAAACGACGGCCAGTgggtgaaattccatcacaaa 154–172 55 °C
R-acaaatgcagatgtacaaaaaata
rs11266282 F-ccaaagatgaccgtgag 666 60 °C
F-ctgccaatgttctggatgt
rs11771 F-tggggttttaggtggtga 350 56 °C
F-aaatgcaaagggtgatgc
DXS1069 M13 tailed-F-CGTTGTAAAACGACGGCCAGTagcctaacccacataacagc 254–268 55 °C
R-agctactatattnaccttggtcttg
DXS1068 F-cctctaaagcatagggtcca 245–259 55 °C
R-cccatctgagaacacgctg
DXS8109 M13 tailed-F-CGTTGTAAAACGACGGCCAGTacaggctcggcttattaggg 229–239 55 °C
R-5′-ctttcagtgccaggcatagg
rs6623918 F-5′-tctatttccttactttcccaca 436 58 °C
R-5′-ggaccctttccgcttgat
rs5923859 F-5′-tattgttgtaaggtgggc 379 56 °C
R-5′-cttggcttctgctgatat
DXS6803 M13 tailed-F-CGTTGTAAAACGACGGCCAGTgaaatgtgctttgacaggaa 110–126 55 °C
R-5′-caaaaagggacatatgctactt-3′
DXS1196 M13 tailed-F-CGTTGTAAAACGACGGCCAGTctaaattctcctccaccgtg 209–227 55 °C
R-tttccagagcagattttcagt
DXS1222 M13 tailed-F-CGTTGTAAAACGACGGCCAGTgcaaaaatccccagcc 234–240 55 °C
R-ttcattgccatccagattc
DXS8074 M13 tailed-F-CGTTGTAAAACGACGGCCAGTataaattagccagaggtgttg 221–231 55 °C
R-5′-ctaggtgtgtctgtaaaggtagg-3′
DXS1211 M13 tailed-F-CGTTGTAAAACGACGGCCAGTccctccaatctggcagaa 159–175 55 °C
R-aagacctgggtttggcct
DXS984 M13 tailed-F-CGTTGTAAAACGACGGCCAGTtttctgtctgccaagtgttt 154–184 55 °C
R-tactgngccctactccattc
DXS1205 M13 tailed-F-CGTTGTAAAACGACGGCCAGTcctacgcatgtggctc 184–202 55 °C
R-attaatggcttagagtactttttca
DXS1227 F-agaggtccgagtcttccac 77–99 55 °C
R-ataagggtttactcccccaa
M13 probe CGTTGTAAAACGACGGCCAGT 21 x
Primers used to amplify DNA fragments encompassing the twelve microsatellite markers (DXS8090, DXS1069, DXS1068,
DXS8109,  DXS6803, DXS1196, DXS1222, DXS8074, DXS1211, DXS984, DXS1205, and DXS1227) and the four SNPs
(rs11771, rs11266282, rs5923859, and rs6623918).
TABLE 2. ENZYME AND DIGESTION FRAGMENTS FOR RFLP ANALYSIS OF TWO SNPS
SNP Genotype Enzyme Digestion fragments (bp)
rs11771 C HindIII 350
T   251/99
rs11266282 T HinfI 379/191/96
A   271/191/108/96
Note: There are only two genotypes of each SNP because two makers lies in X chromosome and two groups of samples are all male.
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417Xp21.1–q21.2  between  Chinese  with  LHON  and  normal
controls.
METHODS
Patients:  One  hundred  and  seventy-five  unrelated  male
LHON probands with the G11778A mutation were identified
from our clinic based on mutational detection of G11778A by
allele-specific amplification and single-strand conformational
polymorphism  analysis  as  previously  described  [8,21].  In
addition, one hundred unrelated normal males (age, gender,
and  birth-place  matched)  participated.  Of  the  175  LHON
patients, 55 had a family history of LHON. All participating
individuals were from the central and southeast region of
China.  Informed  consent  was  obtained  from  participants
before the study, conforming to the tenets of the Declaration
of Helsinki and following the Guidance for Sample Collection
of  Human  Genetic  Disease  (National  863-Plan)  by  the
Ministry of Public Health of China. This study was approved
by the Institute Review Board of the Zhongshan Ophthalmic
Center. Genomic DNA was prepared from venous leukocytes.
Genotyping of microsatellite markers: We genotyped twelve
microsatellite  markers,  including  seven  microsatellite
markers  (DXS8090,  DXS1069,  DXS1068,  DXS6803,
DXS8109, DXS1196, and DXS1222) in the Xp21.1–q21.2
region and five microsatellite markers (DXS8074, DXS1211,
DXS984, DXS1205, and DXS1227) in the Xq25–27.2 region.
Genotyping primers for DXS1068 and DXS1227 (Table 1)
were from Panel 28 of the ABI Linkage Mapping Set v2.5
(Applied Biosystems, Foster City, CA). An M13-tailed primer
PCR  method  [39]  was  used  to  genotype  the  other  ten
microsatellite markers where a 5′6-FAM labeled M13 probe
was used (Table 1). The reaction mixture was composed of
0.5 μl reverse primer (10 μM), 0.125 μl M13-tailed forward
primer  (10  μM),  0.375  μl  5′6-FAM  labeled  M13  probe
Figure  1.  Polymerase  chain  reaction-
restriction  fragment  length
polymorphism (PCR-RFLP) analysis of
rs11771  and  rs11266282  in  LHON
patients and normal controls. A: The C/
T genotype of rs11771 in the DYNLT3
gene  was  analyzed  using  HindIII
digestion.  B:  The  T/A  genotype  of
rs11266282 in the LANCL3 gene was
analyzed using HinfI digestion. M: Size
marker  of  50  bp  DNA  ladder  (from
bottom to top: 50 bp, 100 bp, 150 bp, 200
bp, 250 bp, 300 bp, 350 bp, 400 bp, 450
bp, 500 bp, 600 bp, 700 bp, 800 bp, 900
bp, and 1000 bp).
Figure 2. Ideogram of the modifier loci
for  LHON  on  the  X-chromosome.
Auburn and blue lines show the results
of Hudson et al. [28] and Shankar et al.
[29],  respectively,  where  the
nonparametric linkage score (NPL) is
listed on the left vertical axis. Black line
shows the results of our study, where the
–log (p value) on the right vertical axis.
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418TABLE 3. THE GENOTYPES DISTRIBUTION OF TWELVE MICROSATELLITE MARKERS BETWEEN THE LHON PATIENTS AND NORMAL
CONTROLS.
Genotype Length (bp) LHON (n=175) Normal controls
(n=100)
χ2 value p value
DXS8090 152 1 0 7.826 0.55
154 5 4
156 1 1
158 10 2
160 21 8
162 43 32
164 74 47
166 14 5
168 5 1
170 1 0
DXS1069 253 2 1 4.3 0.335
255 30 24
257 137 73
257 4 0
263 2 2
DXS1068 251 2 1 6.458 0.472
253 64 28
255 8 3
257 21 14
259 63 47
261 10 4
263 0 1
265 1 0
DXS8109 221 1 0 9.247 0.262
225 0 1
227 3 3
229 3 0
231 13 15
233 133 68
235 15 9
237 5 4
241 2 0
DXS6803 106 2 3 37.174 2.45×10–5
108 1 0
110 28 12
112 11 9
114 31 11
116 44 48
118 47 5
120 1 0
122 10 10
126 0 1
DXS1196 204 1 0 10.26 0.591
206 2 0
208 53 23
Molecular Vision 2010; 16:416-424 <http://www.molvis.org/molvis/v16/a47> © 2010 Molecular Vision
419TABLE 3. CONTINUED.
Genotype Length (bp) LHON (n=175) Normal controls
(n=100)
χ2 value p value
210 72 46
212 12 13
214 15 6
216 3 2
218 1 0
220 6 2
222 4 3
224 2 3
226 3 0
228 1 1
DXS1222 227 0 1 3.733 0.897
229 2 2
231 29 16
233 102 60
235 26 12
237 14 9
239 1 0
241 1 0
DXS8074 220 143 88 3.393 0.51
222 3 0
224 1 0
226 27 11
228 1 1
DXS1211 157 48 32 3.662 0.925
159 1 0
161 45 24
163 27 10
165 1 1
167 7 3
169 8 5
171 32 22
173 6 3
DXS984 161 1 0 33.879 1.659×10–6
163 1 1
165 40 11
167 98 76
169 30 2
171 0 2
173 1 1
175 2 6
179 2 0
DXS1205 179 3 1 12.365 0.402
181 4 3
183 18 7
185 3 2
187 6 4
189 28 10
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420(TaKaRa  Biotechnology,  Dalian,  China;  10  μM),  2  μl
Template DNA (40 ng/μl), 0.2 μl rTaq polymerase (5 U/μl),
0.8 μl dNTP (2.5 mM each), and ddH2O to a total volume of
10  μl.  PCR  amplification  was  performed  for  the  initial
denaturation at 94 °C for 8 min, followed by 10 cycles of
amplification at 94 °C for 15 s, 55 °C for 15 s, and 72 °C for
30 s, an additional 20 cycles of amplification at 89 °C for 15
s, 55 °C for 15 s, and 72 °C for 30 s, and a final extension at
72 °C for 10 min.
Fluorescence-labeled PCR products were separated by
capillary electrophoresis using an ABI 3100 genetic analyzer.
The  lengths  of  the  PCR  products  were  calculated  using
GeneScanTM  400HD  size  standards  and  analyzed  using
Genemapper  software  (Applied  Biosystems).  For  the  ten
microsatellite  markers  using  the  M13-tailed  primer  PCR
method, the length of fragments was adjusted (the real length
being 21 bp shorter due to the addition of a 21 bp M13-tailed
probe on the forward primer).
Genotyping of single nucleotide polymorphisms: Four SNPs
were genotyped. Of the four, rs11771 and rs11266282 in the
Xp21.1–q21.2 region were genotyped by polymerase chain
reaction  (PCR)-restriction  fragment  length  polymorphism
analysis, where the amplicons were digested by the restriction
endonucleases HindIII and HinfI (TaKaRa Biotechnology),
respectively (Table 2). The digested products were separated
by  10%  PAGE  (PAGE;  Figure  1).  The  other  two  SNPs
(rs6623918 and rs5923859) in the Xp21.1–q21.2 region were
genotyped by cycle sequencing. The primers used to amplify
the fragments harboring these four SNPs are listed in Table 1.
Statistical  analysis:  Distributions  of  the  genotype  and
haplogroup frequencies of the sixteen markers in the Xp21.1–
q21.2  and  Xq25–27.2  regions  were  compared  between
patients and controls using the chi-square or Fisher’s exact
TABLE 3. CONTINUED.
Genotype Length (bp) LHON (n=175) Normal controls
(n=100)
χ2 value p value
185 3 2
187 6 4
189 28 10
191 60 48
193 26 7
195 2 4
197 5 3
199 12 7
201 2 2
203 3 2
DXS1227 77 1 0 10.058 0.196
79 4 1
83 108 59
85 33 15
87 2 2
89 2 0
91 19 21
95 6 1
97 0 1
Note: The Fisher' s exact test was used to compare the frequency of the twelve microsatellites between the two groups.
TABLE 4. THE GENOTYPE DISTRIBUTION OF THE FOUR SNPS BETWEEN THE LHON PATIENTS AND CONTROLS
Genotype
SNP LHON (n=175) Controls (n=100) χ2 P
rs11266282 A (117) T (53) A (61) T (37) 1.206 0.272
rs11771 C (133) T (42) C (80) T (20) 0.583 0.445
rs6623918 G (150) A (25) G (81) A (19) 1.052 0.305
rs5923859 A (142) G (32) A (89) G (11) 2.622 0.105
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421test  (SPSS13.0,  Chicago,  IL).  The  haplotypes  of  the  two
reported markers (DXS8090 and DXS1068) were constructed
using PHASE software. A p value of 0.05 or less was regarded
as statistically significant, based on previous reports [28].
RESULTS
Twelve  microsatellite  markers  and  four  SNPs  were
successfully genotyped except for a few samples (which failed
to generate amplicons after several attempts). The locations
of the analyzed markers on the X-chromosome are shown in
Figure 2. The genotyping results for the twelve microsatellite
markers are listed in Table 3 and for the four SNPs in Table
4. Two of the sixteen markers yielded significant differences
between  cases  and  controls,  namely  DXS6803  (χ2=37.17,
p=2.45×10−5)  and  DXS984  (χ2=33.88,  p=1.66×10−6).  No
statistically  significant  difference  was  found  in  the
distribution of genotyping frequencies for the other fourteen
markers between LHON patients and controls (Table 3, Figure
2).
Haplotypes of the reported markers DXS8090/DXS1068
were constructed using PHASE software (Table 5). There was
no statistically significant difference in the distributions of
these  reported  haplotypes  between  LHON  patients  and
controls.
DISCUSSION
Several studies have shown that the incomplete penetrance
and sex bias of LHON are associated with nuclear modifier
genes  on  the  X-chromosome.  Recently,  DXS8090  (166)/
DXS1068 (258) haplotypes in the Xp21.1–q21.2 region were
shown  to  modulate  the  clinical  expression  of  LHON  in
European  patients  [28].  This  effect  is  independent  of  the
mtDNA genetic background and could explain the variable
penetrance and sex bias well in these pedigrees. Our results
failed to confirm any DXS8090/DXS1068 haplotype with
LHON expression among Chinese, but did find a significant
difference  in  a  nearby  marker  (DXS6803:  χ2=37.17,
p=2.45×10−5) in the Xp21.1–q21.2 region. This marker is
located in the broader linkage region but not in the highly
significant fine mapping region reported by Hudson et al.
[28]. In addition, our study design of case–control series is
different from that of Hudson et al. [28] whose controls were
unaffected family members, which may partly explain our
discrepant  findings.  However,  a  common  locus  may  be
detected by either strategy unless it is ethnic-specific.
In a recent study, X-chromosomal linkage analysis in a
large  Brazilian  family  with  a  G11778A  mutation  on  a
haplogroup  J  background  revealed  a  novel  LHON
susceptibility  locus  on  chromosome  Xq25–27.2  [29].  We
genotyped five microsatellite markers (DXS8074, DXS1211,
TABLE 5. THE DISTRIBUTION OF DXS8090-DXS1068 HAPLOTYPE BETWEEN THE LHON PATIENTS AND NORMAL CONTROLS
Number DXS8090-DXS1068 LHON (n=175) Controls (n=100)
1 164 251 1 (1%) 1 (1%)
2 154 253 2 (1%) 1 (1%)
3 160 253 8 (5%) 2 (2%)
4 162 253 19 (11%) 14 (14%)
5 164 253 23 (13%) 10 (10%)
6 166 253 6 (3%) 1 (1%)
7 160 255 2 (1%) 1 (1%)
8 162 255 3 (2%) 1 (1%)
9 164 255 2 (1%) 1 (1%)
10 154 257 1 (1%) 1 (1%)
11 160 257 1 (1%) 1 (1%)
12 162 257 8 (5%) 4 (4%)
13 164 257 7 (4%) 7 (7%)
14 158 259 4 (2%) 1 (1%)
15 160 259 6 (3%) 4 (4%)
16 162 259 8 (5%) 10 (10%)
17 164 259 34 (19%) 25 (25%)
18 166 259 6 (3%) 4 (4%)
19 168 259 2 (1%) 1 (1%)
20 162 261 1 (1%) 2 (2%)
21 164 261 5 (3%) 1 (1%)
22 other haplotypes 26 (15%) 7 (7%)
Note: The χ2 value of Fisher's exact test was 12.468 and p value was 0.931.
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422DXS984, DXS1205, and DXS1227) in the Xq25–27.2 region.
Our  results  showed  that  DXS984  differed  significantly
(χ2=33.88,  p=1.66×10−6)  between  LHON  patients  and
controls, supporting a possible modifier locus in this region.
These results need to be confirmed by additional studies, as
two other nearby markers (DXS1211 and DXS1205) did not
support the association.
Significant  association  for  isolated  markers  is  not
uncommon and has been reported even in a genome-wide
association study [40]. Replication and confirmation remains
a  challenge  in  association  studies.  Considering  that  most
genetic  risk  factors  (about  95%)  reported  for  many  other
complex traits have been false positives [30-33], we must
interpret our results with caution at this stage. Further linkage
and  genome-wide  association  studies  on  Chinese  families
with LHON are essential to provide additional information
about the X-linked modifier gene in the Chinese population.
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